About IS-IBCD
With unprecedented technological advances and improvement of our knowledge in the pathophysiology of diseases, immunological biotherapies - such as immunotherapy, new vaccine strategies, cell and gene therapies - now represent innovative therapeutic strategies.
These new treatments, on their own or combine with conventional therapeutics, revolutionize the fields of applications in medicine with the development of more effective therapeutic approaches or personalized for patients.
That is why many pharmaceutical industries invest heavily in research and development biotherapies to propose new therapeutic products.
It is therefore necessary to provide a high level of training provided by the best specialists in the field.
This teaching will bring you an extensive knowledge on these new therapeutic tools, from their concept to their development to clinical trials, which will allow you to understand the challenges and problems of the new medical approaches, and promote your professional integration.
Teaching program 2019
- June 17th to 21st
More information about the program
Location
- Paris, Sorbonne Université
- New York, Icahn School of Medicine at Mount Sinai
- Sao Paulo, Universidade de São Paulo
Contact us
Miriam MERAD
François LEMOINE
Roger CHAMMAS
Rachel Fabre - Secretary
ORGANIZERS :
Miriam Merad, MD, PhD, is a Professor of Oncological Science and of Medicine (Hem/Onc division) at the Icahn School of Medicine at Mount Sinai in New York.
Dr. Merad’s laboratory studies the mechanisms that regulate the...